Typicality: | 0.283 |
Saliency: | 0.078 |
in the two trials | 4 | temporal |
amputation → receive → canagliflozin | 4 |
negative | neutral | positive |
0.374 | 0.579 | 0.047 |
Raw frequency | 4 |
Normalized frequency | 0.078 |
Modifier score | 0.500 |
Perplexity | 152.101 |